The disruption of MYC targets is also noteworthy, since MYC impairs myeloid differentiation and promotes the proliferation and survival of hematopoietic stem cells and multipotent progenitors to drive myeloproliferative neoplasms [21]. This evidence concerns the gene MYC and myeloproliferative disorder.